WHO Pauses Hydroxychloroquine <br />Medical Trials for COVID-19 The move comes after a report linked the drug to an <br />increased fatality rate among those with coronavirus. The study in medical journal 'The Lancet' <br />adds that it can increase odds of heart failure <br />in coronavirus patients. The decision has been confirmed by <br />World Health Organization director-general <br />Tedros Adhanom Ghebreyesus. Tedros Adhanom Ghebreyesus WHO chief scientist Soumya Swaminathan adds that <br />more research on hydroxychloroquine is needed. Soumya Swaminathan Further trials conducted in the U.S. and France claim hydroxychloroquine won't help battle the pandemic. Hydroxychloroquine can help treat malaria and lupus, <br />but its effectiveness against COVID-19 remains unknown. President Donald Trump has often claimed that <br />hydroxychloroquine is useful against the coronavirus. Trump even recently said that he was <br />personally taking the drug as a precaution.
